Alkermes plc. ALKS

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $49.06
Market Cap $8.24B
P/E Ratio 34.31
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-5.2% YoY
$1.48B
3-Yr CAGR: 9.9%
Net Income ↓-34.2% YoY
$241.66M
Net Margin: 16.4%
Free Cash Flow ↑18.4% YoY
$480.33M
FCF Yield: 5.83%
EPS (Diluted) ↓-34.1% YoY
$1.43
Basic: $1.47
Return on Equity Efficiency
13.3%
ROA: 305.6%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ALKS)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $745.7M $613.6M $-208.4M $-1.38 $-63.8M $-107.5M
FY 2017 $903.4M +21.1% $748.6M $-157.9M +24.2% $-1.03 +25.4% $19.2M $-32.1M +70.1%
FY 2018 $1,094.3M +21.1% $917.9M $-139.3M +11.8% $-0.90 +12.6% $99.3M $29.9M +193.0%
FY 2019 $1,170.9M +7.0% $990.6M $-196.6M -41.1% $-1.25 -38.9% $72.1M $-18.9M -163.2%
FY 2020 $1,038.8M -11.3% $860.4M $-110.9M +43.6% $-0.70 +44.0% $82.8M $40.6M +315.3%
FY 2021 $1,173.8M +13.0% $976.4M $-48.2M +56.6% $-0.30 +57.1% $101.7M $73.7M +81.4%
FY 2022 $1,111.8M -5.3% $893.7M $-158.3M -228.6% $-0.97 -223.3% $21.0M $-17.2M -123.4%
FY 2023 $1,663.4M +49.6% $1,410.4M $355.8M +324.8% $2.10 +316.5% $401.4M $353.3M +2,152.8%
FY 2024 $1,557.6M -6.4% $1,312.3M $367.1M +3.2% $2.17 +3.3% $439.1M $405.6M +14.8%
FY 2025 $1,475.9M -5.2% $1,279.4M $241.7M -34.2% $1.43 -34.1% $520.8M $480.3M +18.4%
$

Valuation

Market Price $49.06
Market Cap $8.24B
Enterprise Value N/A
P/E Ratio 34.31
P/B Ratio 4.49
FCF Yield 5.83%
Dividend Yield N/A
Shares Outstanding 166,675,800
%

Profitability & Margins

Gross Margin 86.69%
Operating Margin 17.21%
Net Margin 16.37%
Return on Equity (ROE) 13.28%
Return on Assets (ROA) 305.56%
Asset Turnover 18.66x
Revenue 3-Yr CAGR 9.90%
🛡️

Financial Health & Liquidity

Current Ratio 0.15
Cash Ratio 0.72
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $388.57M
Total Debt N/A
Book Value / Share $10.92
💧

Cash Flow Efficiency

Operating Cash Flow $520.75M
Capital Expenditures (CapEx) $40.42M
Free Cash Flow $480.33M
OCF / Revenue 35.28%
FCF / Revenue 32.55%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $1.43
EPS (Basic) $1.47
Dividends / Share N/A
Book Value / Share $10.92
EPS YoY Growth -34.10%
🏛️

Balance Sheet (FY 2025)

Total Assets $79.09M
Total Liabilities $543.44M
Stockholders' Equity $1.82B
Current Assets $79.09M
Current Liabilities $543.44M